Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06069245 · ClinicalTrials.gov registry record · NA

MitoQ & Cardiopulmonary Responses During Exercise

A NA study, sponsored by Ball State University.

Completed
Registry status
NA
Development phase
9
Enrollment target

NCT06069245 is a NA study that has completed, run by Ball State University. The registered enrollment target is 9 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06069245, a NA study, has completed, sponsored by Ball State University.

COMPLETED
Registry status
NA
Development phase
9 participants
Enrollment target

Study Summary

Study Purpose: To examine the acute effects of antioxidant supplementation on energy use during a single bout of exercise in apparently healthy adult men and women. Specifically this study examined the acute effect of MitoQ on: 1. cardiopulmonary responses to submax and maximal exercise 2. Energy expenditure and fat/carbohydrate oxidation during sub maximal exercise. In a double-blind, randomized, placebo controlled, cross-over study design, participants performed 2 experimental trials which differed only in the supplement consumed (MitoQ or Placebo). Participants performed identical exercise protocols which consisted of a series of submaximal workloads followed by a ramp protocol to volitional exhaustion.

Interventions

  • DIETARY_SUPPLEMENT Placebo
  • DIETARY_SUPPLEMENT MitoQ

Trial Details

FieldValue
Enrollment Target 9 participants
Start Date 2022-09-14
Est. Completion 2023-04-30
Phase NA

Sponsor

Ball State University

12 total trials

What the Registry Record Tells You About NCT06069245

The ClinicalTrials.gov registry entry for NCT06069245 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 9 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ball State University, which has 12 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.

NCT06069245 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06069245 about?

NCT06069245 is a clinical study titled "MitoQ & Cardiopulmonary Responses During Exercise". Study Purpose: To examine the acute effects of antioxidant supplementation on energy use during a single bout of exercise in apparently healthy adult men and women. Specifically this study examined the acute effect of MitoQ on: 1. cardiopulmonary responses to submax and maximal exercise 2. Energy ...

What is the current status of trial NCT06069245?

This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2022-09-14. Estimated completion is 2023-04-30.

What interventions are being tested in trial NCT06069245?

The interventions under investigation include: Placebo (DIETARY_SUPPLEMENT), MitoQ (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06069245?

This trial is sponsored by Ball State University, which has 12 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.